Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.58 |
| ▸ | GAA | P10253 | 2/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.47 |
| ▸ | TSHR | P16473 | 3/20 | 0.47 |
| ▸ | CA1 | P00915 | 3/20 | 0.46 |
| ▸ | CA2 | P00918 | 3/20 | 0.46 |
| ▸ | CA9 | Q16790 | 3/20 | 0.46 |
| ▸ | CA3 | P07451 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.44 |
| ▸ | GSK3B | P49841 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.36 |
| ▸ | TP53 | P04637 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | NOS3 | P29474 | 1/20 | 0.36 |
| ▸ | NOS1 | P29475 | 1/20 | 0.36 |
| ▸ | NOS2 | P35228 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.35 |
| ▸ | ALDH3A1 | P30838 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6560116 | 0.97 | MAPT (0.55) | MAPTGAAALDH1A1TSHRCA1 | |
| SCHEMBL1814354 | 0.86 | MAPT (0.43) | MAPTGAAALDH1A1TSHRCA1 | |
| SCHEMBL80048 | 0.86 | KDM4E (0.45) | MAPTGAAALDH1A1TSHRCA1 | |
| Bromide SCHEMBL10915130 | 0.84 | KDM4E (0.43) | MAPTGAAALDH1A1TSHRCA1 | |
| SCHEMBL24629872 | 0.82 | CA1 (0.50) | MAPTGAAALDH1A1TSHRCA1 | |
| SCHEMBL6119395 | 0.82 | CA1 (0.50) | MAPTGAAALDH1A1TSHRCA1 | |
| SCHEMBL1394520 | 0.82 | CA1 (0.50) | MAPTGAAALDH1A1TSHRCA1 | |
| SCHEMBL5430807 | 0.78 | HTT (0.39) | MAPTGAAALDH1A1TSHRCA1 | |
| SCHEMBL15906147 | 0.78 | MAPT (0.55) | MAPTGAAALDH1A1KDM4ECYP3A4 | |
| SCHEMBL6119760 | 0.78 | ADRB2 (0.44) | MAPTGAAALDH1A1TSHRCA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 248 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119798252-A | Method for preparing N-ortho-acyl substituted nitrogen-containing heterocyclic compound and amine-shrinking iron (II) complex thereof | 中国石油化工股份有限公司 | 2025-04-11 | — | — | CN | claimed |
| CN-119707773-A | Preparation method and application of maleimide structure-containing compound | 中国农业大学 | 2025-03-28 | — | — | CN | claimed |
| CN-119143751-A | N-ortho-acyl substituted nitrogen-containing heterocyclic compound and preparation method of amine-shrinking iron (II) complex thereof | 中国石油化工股份有限公司 | 2024-12-17 | — | — | CN | claimed |
| CN-108250046-B | Synthesis method of resveratrol | 上海巧坤化工科技有限公司 | 2023-09-15 | — | — | CN | claimed |
| EP-3225681-B1 | AVIATION FUEL | AFTON CHEMICAL CORP (US) | 2022-05-04 | — | — | EP | claimed |
| CN-114195706-A | N-triphenylimine pyridine ligand, nickel and palladium complex thereof, and preparation and application of complex | 黄山学院 | 2022-03-18 | — | — | CN | claimed |
| CN-113968796-A | Preparation method of azo dye with excellent environment-friendly application performance | 安徽清科瑞洁新材料有限公司 | 2022-01-25 | — | — | CN | claimed |
| CN-108640919-B | Matrine derivative and sophoridine derivative containing aryl amidine or aminoquinoline structure and preparation method thereof | 广西大学 | 2020-09-08 | — | — | CN | claimed |
| US-20170283728-A1 | AVIATION FUEL ADDITIVE SCAVENGER | AFTON CHEMICAL CORPORATION | 2017-10-05 | — | — | US | claimed |
| EP-3225681-A1 | AVIATION FUEL ADDITIVE SCAVENGER | Afton Chemical Corporation (US) | 2017-10-04 | — | — | EP | claimed |
| CN-103804428-B | The preparation method of a kind of coordination compound and the application of coordination compound | 中国石油化工股份有限公司 | 2016-12-21 | — | — | CN | claimed |
| EP-1066269-B1 | TRISUBSTITUTED 1,3,5-TRIAZINE DERIVATIVES FOR TREATMENT OF HIV INFECTIONS | JANSSEN PHARMACEUTICA NV (BE) | 2005-05-11 | — | — | EP | claimed |
| US-20020115668-A1 | Trisubstituted 1,3,5-triazine derivatives | DAEYAERT FREDERIK FRANS DESIRE (BE) | 2002-08-22 | — | — | US | claimed |
| EP-1066269-A1 | TRISUBSTITUTED 1,3,5-TRIAZINE DERIVATIVES FOR TREATMENT OF HIV INFECTIONS | JANSSEN PHARMACEUTICA N.V. (BE) | 2001-01-10 | — | — | EP | claimed |
| US-6150360-A | ADMINISTERING TO A PATIENT SUFFERING FROM HUMAN IMMUNODEFICIENCY VIRUS INFECTION A TRISUBSTITUTED 1,3,5-TRIAZINE DERIVATIVE | JANSSEN PHARMACEUTICA N.V. (BE) | 2000-11-21 | — | — | US | claimed |
| WO-1999050256-A1 | TRISUBSTITUTED 1,3,5-TRIAZINE DERIVATIVES FOR TREATMENT OF HIV INFECTIONS | JANSSEN PHARMACEUTICA N.V. (BE) | 1999-10-07 | — | — | WO | claimed |
| CN-116621729-B | Perfluoro phenyl substituted salicylaldimine nickel complex, preparation method and application thereof | 华东理工大学 | 2025-06-24 | — | — | CN | disclosed |
| CN-119798252-A | Method for preparing N-ortho-acyl substituted nitrogen-containing heterocyclic compound and amine-shrinking iron (II) complex thereof | 中国石油化工股份有限公司 | 2025-04-11 | — | — | CN | disclosed |
| US-3978040-A | Process for the preparation of cyanoazo compounds by reacting halogenoazo compounds with CuCN in an aqueous media in the presence of a nitrogen base | BAYER AKTIENGESELLSCHAFT (DT) | 1976-08-31 | — | — | US | disclosed |
| US-3962209-A | PROCESS FOR PREPARING AZO DYESTUFFS WITH ORTHO-AZO CYANO GROUPS BY CYANO EXCHANGE OF METAL CYANIDES AND HALO DYESTUFFS | BAYER AKTIENGESELLSCHAFT (DT) | 1976-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020115668-A1 | Trisubstituted 1,3,5-triazine derivatives | XDH, CCR5, CXCR1 | MAPT 4642/4885GAA 4227/4885ALDH1A1 3722/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.